Neurology Research International, published by HINDAWI LTD, is an esteemed open access journal that has been serving the neurology community since 2010. With its ISSN 2090-1852 and E-ISSN 2090-1860, this journal aims to foster knowledge dissemination and facilitate dialogue surrounding key issues in neurology and clinical neuroscience, making it a vital resource for researchers, clinicians, and students alike. It operates from the United States, with its administrative hub located in London, England. As of 2023, the journal has been positioned in the Q3 category for both neurology and clinical neurology, reflecting its commitment to advancing research within these critical fields. With a current Scopus rank of #216/400 in clinical neurology and a #113/192 in neuroscience, and a converged publication timeline from 2010 to 2024, Neurology Research International is dedicated to promoting high-quality research that addresses contemporary challenges and innovations in neurological science. By offering open access since its inception, it ensures that cutting-edge research is freely available, aligning with the global push towards accessible scientific communication.

Welcome to the JOURNAL OF VASCULAR RESEARCH, a reputable academic journal published by KARGER that has been a cornerstone of vascular research since 1964. With an ISSN of 1018-1172 and an E-ISSN of 1423-0135, this journal plays a vital role in disseminating cutting-edge research in the fields of Cardiology and Cardiovascular Medicine and Physiology. Currently categorized in the Q3 quartile for both disciplines, it ranks as #179 in Cardiology and #131 in Physiology according to Scopus, showcasing its significant contribution to the scientific community. Although the journal operates on a subscription basis, it strives to provide accessible content that informs and inspires researchers, professionals, and students alike. As the journal looks forward to its convergence in 2024, it continues to uphold its mission of advancing knowledge, fostering innovation, and encouraging collaboration within the dynamic realm of vascular research.

AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, published by Elsevier, stands as a pivotal journal in the fields of Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems, and Neurology (Clinical), boasting an impressive Q2 ranking in the latter two categories as of 2023. This journal, which has been in circulation since 2000, provides a vital platform for disseminating innovative research pertaining to the autonomic nervous system's fundamental and clinical aspects, thus addressing significant challenges in both theoretical understanding and clinical application. Researchers and practitioners worldwide find value in its comprehensive articles, reviews, and case studies that explore the intricacies of autonomic neurobiology. As part of Elsevier's prestigious portfolio, the journal offers options for Open Access, enhancing the visibility and accessibility of its content. With an increasing impact on clinical practices and research directions, AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL serves as an essential resource for advancing knowledge and fostering collaboration among scholars, clinicians, and students dedicated to unraveling the complexities of the autonomic nervous system.

Neuron is a premier journal in the field of neuroscience, published by CELL PRESS in the United States. Since its inception in 1988, this esteemed publication has been at the forefront of neuroscientific research and continues to shape our understanding of the brain and nervous system. With an impressive 2023 Scopus rank of #5 out of 113 in General Neuroscience and a notable Q1 quartile classification, Neuron is recognized for its high-quality, impactful contributions to both established and emerging areas of neuroscience. The journal does not operate under an open access model, yet it offers unparalleled insights and rigorous peer-reviewed research that are essential for researchers, professionals, and students alike. By publishing cutting-edge findings and fostering critical discussions, Neuron plays a vital role in advancing our collective knowledge in this constantly evolving field, making it an indispensable resource for anyone aiming to stay ahead in neuroscience research.

Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.

The Journal of Cachexia Sarcopenia and Muscle is a premier open-access publication dedicated to advancing the understanding of muscle wasting, cachexia, and related disorders. Published by Wiley, this esteemed journal boasts an impressive impact within its fields, achieving a Q1 classification in both Orthopedics and Sports Medicine, and Physiology (Medical) for 2023. With a Scopus ranking of #4 out of 321 in Orthopedics and Sports Medicine, and #10 out of 113 in Physiology, it firmly positions itself at the forefront of medical research. The journal’s scope includes comprehensive studies, reviews, and innovative clinical trials that contribute to the scientific community’s understanding of muscle health and performance. Since its inception in 2010 as an open-access platform, the Journal of Cachexia Sarcopenia and Muscle has facilitated a growing dialogue among researchers, healthcare professionals, and students, emphasizing its crucial role in tackling the multifaceted challenges posed by muscle diseases. For those invested in the latest research trends and clinical advancements, this journal stands out as a vital resource and reference point.

DYSPHAGIA, published by Springer, is a premier journal dedicated to advancing the study of swallowing disorders, a critical area within the fields of Gastroenterology, Otorhinolaryngology, and Speech and Hearing. With an ISSN of 0179-051X and E-ISSN 1432-0460, this journal serves as a vital resource for researchers, clinicians, and students alike, providing cutting-edge research and reviews that inform clinical practice and enhance patient care. As a testament to its influence, DYSPHAGIA holds a Q2 ranking in Gastroenterology and Q1 rankings in both Otorhinolaryngology and Speech and Hearing for 2023. Its Scopus rankings further position it among the leading journals in its field, highlighting its importance and impact within the academic community. The journal publishes contributions that encompass a spectrum of topics related to swallowing, making it an essential platform for disseminating knowledge and fostering innovative solutions in the management of dysphagia. Operating from New York, NY, DYSPHAGIA invites contributions that align with its mission to advance the understanding and treatment of swallowing disorders through rigorous scientific inquiry and discourse.

Skeletal Muscle is a prestigious open access journal published by BMC, dedicated to advancing the field of muscle biology and its associated disciplines. With an ISSN of 2044-5040, this journal has consistently been a beacon of knowledge and innovation since its inception in 2011. Based in the United Kingdom, Skeletal Muscle has established an impressive reputation as reflected in its category quartile rankings for 2023, achieving Q1 status in Cell Biology, Molecular Biology, and Orthopedics and Sports Medicine. This esteemed journal holds notable Scopus rankings, including a remarkable 12th place out of 321 in Orthopedics and Sports Medicine, positioning it in the 96th percentile. The journal is committed to disseminating high-quality, peer-reviewed research that fosters collaboration among scholars, healthcare professionals, and students alike. With a mission to explore the intricate biological mechanisms underlying skeletal muscle physiology and its impact on health and disease, Skeletal Muscle plays a vital role in shaping the future of research in this critical area, ensuring that cutting-edge findings are accessible to all.

Acta Physiologica is a premier, peer-reviewed journal published by WILEY, dedicated to the dissemination of high-quality research across the field of physiology. With an impressive impact factor reflective of its Q1 category ranking in Physiology for 2023, this journal is a vital resource for researchers, professionals, and students alike, seeking to explore the complexities of biological systems. The journal is indexed with a commendable Scopus rank of #18 out of 193 in its category, placing it within the top 10% of its field, which underscores its influence and citation frequency within the academic community. Acta Physiologica publishes a variety of articles that address fundamental physiological concepts, innovative methodologies, and cross-disciplinary research. With its open access options, the journal ensures that cutting-edge knowledge is readily accessible, fostering an environment of collaboration and advancement in the study of physiology. Spanning from 2006 to 2024, the journal continues to be at the forefront of physiological research and education, encouraging the global sharing of knowledge through its comprehensive content.

Degenerative Neurological and Neuromuscular Disease is a distinguished academic journal published by DOVE MEDICAL PRESS LTD, focusing on the latest advancements in the field of neurology and neuromuscular disorders. With a commitment to disseminating high-quality research, the journal aims to provide a critical platform for researchers, healthcare professionals, and students to share and engage with groundbreaking studies that advance our understanding of degenerative conditions affecting the nervous system. Although the journal's impact factor and h-index are currently not available, its open access model ensures that the valuable findings published within are accessible to a global audience, thereby fostering collaboration and innovation in neurological health. The journal's address is PO BOX 300-008, Albany, Auckland 0752, New Zealand, reflecting its international relevance and commitment to advancing the field of neurology. As the understanding of neurodegenerative diseases and neuromuscular challenges continues to evolve, Degenerative Neurological and Neuromuscular Disease serves as an essential resource for anyone dedicated to improving patient outcomes and advancing scientific knowledge.